Home
About
Overview
Sharing Data
ORCID
Help
History (18)
FRMD4A/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma.
Radioprotection by WR-151327 against the late normal tissue damage in mouse hind legs from gamma ray radiation.
Risk perception and surveillance uptake in individuals at increased risk for pancreatic ductal adenocarcinoma.
The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain.
Hemispheric specialization varies with EEG brain resting states and phase of menstrual cycle.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (12)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Institution
Department
Faculty Rank
Name
Institution
Why
Ravi Salgia
University of Chicago
Why?
Rifat Hasina
University of Chicago
Why?
Everett E. Vokes
University of Chicago
Why?
Mark K. Ferguson
University of Chicago
Why?
Aliya Husain
University of Chicago
Why?
Mark W. Lingen
University of Chicago
Why?
Kenneth S. Cohen
University of Chicago
Why?
Walter M. Stadler
University of Chicago
Why?
Matthew Gayed
University of Chicago
Why?
Theodore Karrison
University of Chicago
Why?
Mitchell C. Posner
University of Chicago
Why?
Alexander V. Chervonsky
University of Chicago
Why?
Per Page
15
25
50
100
Page
of 1
Next
Prev
Search Criteria
Receptor EphB4
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions